Physician

Amer Y Sayed, M.D

According to 2025 Medicare claims, Amer Sayed, M.D (NPI: 1467892372) practices interventional cardiology in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Butler, OH. This provider's primary affiliated billing organization is PREMIER HEALTH SPECIALISTS INC (NPI: 1194958223; TIN: 311741379) and primary practice location at 45005-2584. Sayed is affiliated with the NewYork Quality Care (ACO ID: A2571) and WellStar Clinical Partners Medicare ACO, LLC (ACO ID: A4803), participating under the MSSP model.

Sayed's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 461 traditional Medicare patients, billed 1,262 HCPCS/CPT codes, and received $141,081 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 855 prescription claims across 291 beneficiaries totaling $146,925 in drug costs, led by Eliquis (Apixaban). 2017 DME data shows 30 claims. Open Payments data shows 27 records totaling $3,041. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $10,604 to $141,081. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	77	177	$10,604
2017	178	317	$16,951
2018	48	54	$5,532
2019	171	211	$17,983
2020	50	50	$5,635
2021	175	303	$21,445
2022	435	725	$39,725
2023	211	437	$37,462
2024	461	1,262	$141,081

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	47	297	$17,421
2016	84	357	$19,405
2017	64	232	$16,611
2018	30	59	$1,807
2019	50	74	$2,397
2020	54	85	$2,438
2021	140	175	$2,793
2022	256	465	$24,765
2023	142	225	$21,849
2024	291	855	$146,925

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	30	$1,078
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	89	92	$126
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	104	189	$123
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	141	262	$86
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	169	177	$50
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	43	46	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	66	2,665	$51,968
Farxiga	Dapagliflozin Propanediol	35	1,675	$31,249
Jardiance	Empagliflozin	14	1,020	$20,502
Entresto	Sacubitril/Valsartan	19	695	$14,477
Atorvastatin Calcium	Atorvastatin Calcium	77	5,396	$649

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	27	$3,041	Penumbra, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amer Y. Sayed, M.D?

Tedicare shows public-source Medicare data for Amer Y. Sayed, M.D (NPI 1467892372), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amer Y. Sayed, M.D have ACO affiliation data?

Amer Y. Sayed, M.D is shown with ACO affiliation data for NewYork Quality Care (MSSP, ACO ID A2571) and WellStar Clinical Partners Medicare ACO, LLC (MSSP, ACO ID A4803).

What billing organization is linked to Amer Y. Sayed, M.D?

Amer Y. Sayed, M.D is linked to PREMIER HEALTH SPECIALISTS INC (billing NPI 1194958223) in the available physician profile data.

Does Amer Y. Sayed, M.D have Open Payments data?

Amer Y. Sayed, M.D has 27 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.